DMC is leading the low cost sustainable transformation of multiple product markets. Our novel, patent-pending technology for rapid engineering of robust microbial hosts enables the production of a broad diversity of specialty chemicals, flavors, fragrances, neutracueticals, natural products, pharmaceuticals, and APIs.
Deployment of our Dynamic Metabolic Control technology dramatically reduces the cost and development timeline from discovery to commercial performance. Our ultra low cost development will democratize metabolic engineering efforts, creating a multitude of commercially viable bioprocesses and delivering sustainable routes to both new and existing products.
CEO & Founder
Dr. Lipscomb is CEO and Founder of DMC Limited. His career has included a range of development stages from early R&D to commercial deployment in…
CTO & Founder
Dr. Lynch is CTO and Founder of DMC Limited. He is also an Assistant Professor in the Biomedical Engineering and Chemistry Departments at Duke University.…
Dr. Ryan Gill is the Wilfred and Caroline Slade Endowed Professor of Chemical and Biological Engineering at the University of Colorado, Boulder. Dr. Gill is…
Kyle Lefkoff is a Founder and General Partner of Boulder Ventures Ltd. In his thirty-year career as a venture capitalist in Boulder, Mr. Lefkoff has…
Your Name (required)
Your Email (required)
© 2015-2017, DMC